Timothy E Wilens1,2, Benjamin M Isenberg3, Tamar A Kaminski3, Rachael M Lyons3, Javier Quintero4,5,6. 1. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts General Hospital, YAW 6A, 55 Fruit Street, Boston, MA, 02114, USA. TWilens@partners.org. 2. Department of Psychiatry, Harvard Medical School, Boston, MA, 02115, USA. TWilens@partners.org. 3. Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts General Hospital, YAW 6A, 55 Fruit Street, Boston, MA, 02114, USA. 4. Hospital Universitario Infanta Leonor, Madrid, Spain. 5. Medical School, Complutense University of Madrid, Madrid, Spain. 6. PSIKIDS, Madrid, Spain.
Abstract
PURPOSE OF REVIEW: Extensive research has been conducted on attention-deficit/hyperactivity disorder (ADHD) in children and adults; however, less is known about ADHD during the transition from childhood to adulthood. Transitional aged youth (TAY) with ADHD represents a particularly vulnerable population as their newfound independence and responsibility often coincides with the development of comorbid disorders. The purpose of this review is to provide an update on the evaluation, diagnosis, and treatment of TAY-ADHD. RECENT FINDINGS: Recent studies discovering ADHD symptoms emerging in TAY call the classification of ADHD as a disorder necessarily developing in childhood into question. TAY-ADHD are also shown to be vulnerable to academic and social impairments, increased risky behavior, and comorbid psychiatric disorders. Due to the risk of stimulant diversion in TAY, providers are advised to take precaution when prescribing medication to this population. Recent studies demonstrating the efficacy of psychotherapy in conjunction with non-stimulant or extended release stimulant medication provide a feasible alternative. This review highlights research on the course and evaluation of ADHD, impairments and comorbidities specific to TAY, and treatments tailored to address the unique challenges associated with TAY-ADHD.
PURPOSE OF REVIEW: Extensive research has been conducted on attention-deficit/hyperactivity disorder (ADHD) in children and adults; however, less is known about ADHD during the transition from childhood to adulthood. Transitional aged youth (TAY) with ADHD represents a particularly vulnerable population as their newfound independence and responsibility often coincides with the development of comorbid disorders. The purpose of this review is to provide an update on the evaluation, diagnosis, and treatment of TAY-ADHD. RECENT FINDINGS: Recent studies discovering ADHD symptoms emerging in TAY call the classification of ADHD as a disorder necessarily developing in childhood into question. TAY-ADHD are also shown to be vulnerable to academic and social impairments, increased risky behavior, and comorbid psychiatric disorders. Due to the risk of stimulant diversion in TAY, providers are advised to take precaution when prescribing medication to this population. Recent studies demonstrating the efficacy of psychotherapy in conjunction with non-stimulant or extended release stimulant medication provide a feasible alternative. This review highlights research on the course and evaluation of ADHD, impairments and comorbidities specific to TAY, and treatments tailored to address the unique challenges associated with TAY-ADHD.
Authors: Sean Esteban McCabe; Kara Dickinson; Brady T West; Timothy E Wilens Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-04-07 Impact factor: 8.829
Authors: William B Brinkman; Jeffery N Epstein; Peggy Auinger; Leanne Tamm; Tanya E Froehlich Journal: Drug Alcohol Depend Date: 2014-12-02 Impact factor: 4.492
Authors: Susan E Sprich; Steven A Safren; Daniel Finkelstein; Jocelyn E Remmert; Paul Hammerness Journal: J Child Psychol Psychiatry Date: 2016-03-17 Impact factor: 8.982
Authors: Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Amy L Weaver; Slavica K Katusic Journal: PLoS One Date: 2016-06-13 Impact factor: 3.240
Authors: Timothy E Wilens; Diana W Woodward; Je Deuk Ko; Amy F Berger; Colin Burke; Amy M Yule Journal: J Child Adolesc Psychopharmacol Date: 2022-05-04 Impact factor: 3.031
Authors: Patrick Köck; Maximilian Meyer; Julie Elsner; Kenneth M Dürsteler; Marc Vogel; Marc Walter Journal: Front Psychiatry Date: 2022-02-24 Impact factor: 4.157
Authors: Ann-Kathrin Korfmacher; Oliver Hirsch; Mira-Lynn Chavanon; Björn Albrecht; Hanna Christiansen Journal: Front Psychiatry Date: 2022-08-18 Impact factor: 5.435